日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Overcoming multidrug resistance in gastrointestinal cancers with a CDH17-targeted ADC conjugated to a DNA topoisomerase inhibitor.

利用靶向 CDH17 的 ADC 与 DNA 拓扑异构酶抑制剂偶联,克服胃肠道癌症的多药耐药性

Wang Rui, Fang Peng, Chen Xi, Ji Jiali, Yu Dongan, Mei Fei, Wang Zhenzhen, Zhou Wei, Peng Wenjing, Wang Rongjuan, Wang Jian, Guo Cuicui, Wu Hai, Liu Datao, Tan Xiaoding, Gui Xun

Efficacy, Safety, and Population Pharmacokinetics of MW032 Compared With Denosumab for Solid Tumor-Related Bone Metastases: A Randomized, Double-Blind, Phase 3 Equivalence Trial

MW032 与地诺单抗治疗实体瘤相关骨转移的疗效、安全性和群体药代动力学比较:一项随机、双盲、3期等效性试验

Zhang, Shaohua; Yin, Yongmei; Xiong, Hailin; Wang, Jingfen; Liu, Hu; Lu, Junguo; Zhang, Qingyuan; Zhang, Longzhen; Zhong, Jincai; Nie, Jianyun; Lei, Kaijian; Wang, Hong; Yang, Shu; Yao, Herui; Wu, Huijing; Yu, Ding; Ji, Xuening; Zhang, Hua; Wu, Fang; Xie, Weimin; Li, Wei; Yao, Weirong; Zhong, Diansheng; Sun, Hongmei; Sun, Tao; Guo, Zengqing; Wang, Rui; Guo, Yanzhen; Yu, Zhuang; Li, Dairong; Jin, Hongyan; Song, Haifeng; Chen, Xiaoyuan; Ma, Wen; Hu, Zhitian; Liu, Datao; Guo, Yinhan; Tang, Jinhai; Jiang, Zefei

CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity

CoVac501是一种与TLR7激动剂偶联的自佐剂肽疫苗,可诱导针对SARS-CoV-2的保护性免疫。

Long, Yiru; Sun, Jianhua; Song, Tian-Zhang; Liu, Tingting; Tang, Feng; Zhang, Xinxin; Ding, Longfei; Miao, Yunqiu; Zhu, Weiliang; Pan, Xiaoyan; An, Qi; Qin, Mian; Tong, Xiankun; Peng, Xionghua; Yu, Pan; Zhu, Peng; Xu, Jianqing; Zhang, Xiaoyan; Zhang, Yachun; Liu, Datao; Chen, Ben; Chen, Huilin; Zhang, Leike; Xiao, Gengfu; Zuo, Jianping; Tang, Wei; Zhou, Ji; Li, Heng; Xu, Zhijian; Zheng, Hong-Yi; Long, Xin-Yan; Qin, Qiuping; Gan, Yong; Ren, Jin; Huang, Wei; Zheng, Yong-Tang; Jin, Guangyi; Gong, Likun